lymphoma
Adaptive Biotechnologies Wins Expanded Medicare Coverage of ClonoSeq in Mantle Cell Lymphoma
The expanded coverage adds to the existing Medicare payment structure for ClonoSeq, which provides coverage for a bundle of tests to assess patient therapy response.
Beckman Coulter, IU School of Medicine Win $2.5M NCI Grant to Expand Blood Cancer Testing in Kenya
The partners plan to expand testing for early detection of childhood leukemias and lymphomas, bolster local testing capacity, and conduct a research study.
NeoGenomics, Adaptive Biotech Partner to Offer Combined Blood Cancer Testing
Doctors ordering NeoGenomics Compass test packages will have the option of including Adaptive's ClonoSeq minimal residual disease assay.
Roche Gets FDA Clearance for B-Cell Lymphoma Test
The test is designed to differentiate a B-cell malignancy from a normal, reactive response to an infection.
Qiagen, Denovo Biopharma to Develop Liquid Biopsy CDx Test for Investigational Lymphoma Treatment
The test will identify patients expressing a genomic biomarker who are likely to respond to Denovo's investigational DB102 treatment for diffuse large B-cell lymphoma.